Kelly S. Hayes

Kelly S. Hayes

Auto-generated profile, based on publicly available information

Kelly S. Hayes

School of Biological Sciences, FBMH, MAHSC, University of Manchester, Manchester, United Kingdom

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2018 in Science Advances
Verified
Journal Article
Open access
PDF file
EWEmily C. White
Emily C. White
AHAshley Houlden
Ashley Houlden
ABAllison J. Bancroft
Allison J. Bancroft
KHKelly S. Hayes
Kelly S. Hayes
MGMarie Goldrick
Marie Goldrick
IRIan S. Roberts
Ian S. Roberts
Intestinal dwelling parasites have evolved closely with the complex intestinal microbiota of their host, but the significance of the host microbiota for metazoan pathogens and the role of their own intestinal microbiota are still not fully known. We have found that the parasitic nematode Trichuris muris acquired a distinct intestinal microbiota from its host, which was required for nematode fitness. Infection of germ-free mice and mice monocolonized with Bacteroides thetaiotaomicron demonstrated that successful T. muris infections require a host microbiota. Following infection, T. muris–induced alterations in the host intestinal microbiota inhibited subsequent rounds of infection, controlling parasite numbers within the host intestine. This dual strategy could promote the long-term survival of the parasite within the intestinal niche necessary for successful chronic nematode infection.

3 October 2019 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
LCLaura Campbell
Laura Campbell
MHMatthew R. Hepworth
Matthew R. Hepworth
JWJayde Whittingham-Dowd
Jayde Whittingham-Dowd
STSeona Thompson
Seona Thompson
ABAllison J. Bancroft
Allison J. Bancroft
RGRichard Grencis
Richard Grencis
Host immunity to parasitic nematodes requires the generation of a robust type 2 cytokine response, characterized by the production of interleukin 13 (IL-13), which drives expulsion. Here, we show that infection with helminths in the intestine also induces an ILC2-driven, IL-13–dependent goblet cell hyperplasia and increased production of mucins (Muc5b and Muc5ac) at distal sites, including the lungs and other mucosal barrier sites. Critically, we show that type 2 priming of lung tissue through increased mucin production inhibits the progression of a subsequent lung migratory helminth infection and limits its transit through the airways. These data show that infection by gastrointestinal-dwelling helminths induces a systemic innate mucin response that primes peripheral barrier sites for protection against subsequent secondary helminth infections. These data suggest that innate-driven priming of mucus barriers may have evolved to protect from subsequent infections with multiple helminth species, which occur naturally in endemic areas.

1 April 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
MDMaria Adelaida Duque-Correa
Maria Adelaida Duque-Correa
DGDavid Goulding
David Goulding
FRFaye H. Rodgers
Faye H. Rodgers
JGJ. Andrew Gillis
J. Andrew Gillis
CCClaire Cormie
Claire Cormie
MBMatthew Berriman
Matthew Berriman
Whipworms are large metazoan parasites that inhabit multi-intracellular epithelial tunnels in the large intestine of their hosts, causing chronic disease in humans and other mammals. How first-stage larvae invade host epithelia and establish infection remains unclear. Here we investigate early infection events using both Trichuris muris infections of mice and murine caecaloids, the first in-vitro system for whipworm infection and organoid model for live helminths. We show that larvae degrade mucus layers to access epithelial cells. In early syncytial tunnels, larvae are completely intracellular, woven through multiple live dividing cells. Using single-cell RNA sequencing of infected mouse caecum, we reveal that progression of infection results in cell damage and an expansion of enterocytes expressing of Isg15, potentially instigating the host immune response to the whipworm and tissue repair. Our results unravel intestinal epithelium invasion by whipworms and reveal specific host-parasite interactions that allow the whipworm to establish its multi-intracellular niche.

26 June 2017 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
KHKelly S. Hayes
Kelly S. Hayes
LCLaura J. Cliffe
Laura J. Cliffe
ABAlison J. Bancroft
Alison J. Bancroft
SFSimon P. Forman
Simon P. Forman
STSeona Thompson
Seona Thompson
RGRichard Grencis
Richard Grencis
Incidences of infection-related cancers are on the rise in developing countries where the prevalence of intestinal nematode worm infections are also high. Trichuris muris (T. muris) is a murine gut-dwelling nematode that is the direct model for human T. trichiura, one of the major soil-transmitted helminth infections of humans. In order to assess whether chronic infection with T. muris does indeed influence the development of cancer hallmarks, both wild type mice and colon cancer model (APC min/+) mice were infected with this parasite. Parasite infection in wild type mice led to the development of neoplastic change similar to that seen in mice that had been treated with the carcinogen azoxymethane. Additionally, both chronic and acute infection in the APCmin/+ mice led to an enhanced tumour development that was distinct to the site of infection suggesting systemic control. By blocking the parasite induced T regulatory response in these mice, the increase in the number of tumours following infection was abrogated. Thus T. muris infection alone causes an increase in gut pathologies that are known to be markers of cancer but also increases the incidence of tumour formation in a colon cancer model. The influence of parasitic worm infection on the development of cancer may therefore be significant. It is estimated that now 2 billion people currently live with chronic parasitic worm infections. As the incidences of cancer increase worldwide, the importance of these chronic inflammatory conditions on the development of cancer becomes more important. Several bacterial, viral and parasitic infections are already known to influence cancer development but as colon cancer is particularly prevalent worldwide, we wanted to assess the effect of a large intestinal dwelling worm, Trichuris muris (T. muris) on its aetiology. This whipworm is a natural infection of mice and has significant homology to human whipworm. From our studies, we showed that chronic infection alone induced changes in the caecum of the mouse that were comparable to those seen with a well-known carcinogen. In addition to this, T. muris infection was also able to increase the development of adenomas in the small intestine of mutant mice that spontaneously develop tumours. This change was abrogated if a T regulatory cell type was blocked during infection. The T regulatory cell type that arises during infection has been shown to play an important role in protecting the host from damage caused by the parasite and the immune response to it. The present study using the mouse model however, suggests that regulatory T cells can have negative effects, at least in terms of the development of bowel cancer. As so many people live with chronic, regulated parasitic infections, the importance of the parasites in cancer development may therefore be significant.

28 August 2018 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
NBNeima Briggs
Neima Briggs
JWJunfei Wei
Junfei Wei
LVLeroy Versteeg
Leroy Versteeg
BZBin Zhan
Bin Zhan
BKBrian Keegan
Brian Keegan
PHPeter Hotez
Peter Hotez
Human whipworm (Trichuris trichiura) infects approximately 1 in 15 people worldwide, representing the leading infectious cause of colitis and subsequent, inflammatory bowel disease (IBD). Current control measures focused on mass deworming have had limited success due to low drug efficacies. Vaccination would be an ideal, cost-effective strategy to induce protective immunity, leading to control of infection and transmission. Here we report the identification of whey acidic protein, a whipworm secretory protein, as a strong immunogen for inducing protective efficacy in a surrogate mouse T. muris infection model. The recombinant WAP protein (rTm-WAP49), as well as a single, highly conserved repeat within WAP (fragment 8) expressed as an Na-GST-1 fusion protein (rTm-WAP-F8+Na-GST-1), generate a strong T helper type 2 (Th2) immune response when delivered as subcutaneous vaccines formulated with Montanide ISA 720. Oral challenge with T. muris infective eggs following vaccination led to a significant reduction in worm burden of 48% by rTm-WAP49 and 33% by rTm-WAP-F8+Na-GST-1. The cellular immune correlates of protection included significant antigen-specific production of Th2 cytokines IL-4, IL-9, and IL-13 by cells isolated from the vaccine-draining inguinal lymph nodes, parasite-draining mesenteric lymph nodes, and spleen in mice vaccinated with either rTm-WAP49 or rTm-WAP-F8+Na-GST-1. The humoral immune correlates included a high antigen-specific ratio of IgG1 to IgG2a, without eliciting an IgE-mediated allergic response. Immunofluorescent staining of adult T. muris with WAP antisera identified the worm’s pathogenic stichosome organ as the site of secretion of native Tm-WAP protein into the colonic mucosa. Given the high sequence conservation for the WAP proteins from T. muris and T. trichiura, the results presented here support the WAP protein to be further evaluated as a potential human whipworm vaccine candidate. Human whipworm (Trichuris trichiura) is pervasive intestinal parasite that causes malnutrition and inflammatory bowel disease (IBD), predominately among the world’s most impoverished billion people. Available treatment strategies have had little impact on the disease prevalence or morbidity. A vaccine against human whipworm would provide a low-cost and long-term solution, yet the identification of candidates is lacking. Here we characterize a stichosome-derived whey acidic protein (WAP), dominant among the worm’s excretory and secretory (ES) products, as a potential vaccine candidate. When delivered as a subcutaneous recombinant protein formulated with the clinically relevant adjuvant, Montanide ISA 720, mice were significantly protected against challenge infection. We describe the induced protection as a combined WAP-specific type 2 cellular and humoral immune response. In summary, we have identified an immunogenic whipworm protein that is effective in inducing protective efficacy in an animal model and is a promising human vaccine candidate.

17 October 2007 in Parasite Immunology
Verified
Journal Article
Closed access
PDF file
KHK. S. Hayes
K. S. Hayes
ABA. J. Bancroft
A. J. Bancroft
RGR. K. Grencis
R. K. Grencis